Today: 13 June 2026
Browse Category

Stock Market 18 November 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma shares surged over 30% Tuesday after reporting a patient with advanced hepatocellular carcinoma remained cancer-free for nine years on its drug Namodenoson. The company also began enrolling patients in a pivotal Phase III trial for the treatment in Israel, Europe, and the U.S. Namodenoson holds Orphan Drug and Fast Track designations.
18 November 2025
···
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025

Medtronic shares jumped 4–5% to around $100–101 late Tuesday morning, hitting a three-year high after the company beat fiscal Q2 2026 earnings and revenue forecasts and raised its full-year outlook. Revenue rose 6.6% to $9.0 billion, with adjusted EPS of $1.36 topping analyst estimates. The rally pushed Medtronic’s market cap to about $129 billion. Demand for heart and diabetes devices drove the gains.
18 November 2025
··
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic reported Q2 FY26 revenue of $8.96 billion, up 6.6% year over year, and non-GAAP EPS of $1.36, beating Wall Street estimates. Shares rose 4–5% intraday. Cardiac ablation revenue jumped 71% globally, with 128% growth in the U.S. The company raised its full-year outlook after its fourth straight quarter of beating consensus EPS.
18 November 2025
···
Netflix Stock Soars to Record Highs Amid Bold Deals and Streaming War Shake-Up

Netflix Stock Today, November 18, 2025: NFLX Rises After 10‑for‑1 Split as Wall Street Recalibrates Targets

Netflix shares rose 1.2% to around $111.60 on November 18, 2025, following a 10-for-1 stock split that took effect Monday. Q3 revenue climbed 17% to $11.5 billion, but profit missed forecasts after a $619 million Brazil tax charge. Options trading surged, and speculation grew over a possible Warner Bros. Discovery deal. Barclays and JPMorgan both trimmed their price targets.
18 November 2025
·
Palantir (PLTR) Today: Stock Slips as Valuation Debate Heats Up—Fresh Analyst Notes, $455B Market-Cap Talk, and What’s Next (12.11.2025)

Palantir Stock Today (PLTR): Price, News and Analysis for November 18, 2025

Palantir shares fell 2–3% to around $167 on November 18, extending a weeklong slide that leaves the stock nearly 20% below its early-November record high. The drop comes amid persistent concerns over extreme valuations, with trailing P/E ratios near 1,700x and price-to-sales above 100x, despite strong business performance. Major investors remain divided, and trading volume topped 20 million shares.
18 November 2025
··
VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI fell 1.04% Monday and is down 2.11% over five days as tech-valuation concerns and anticipation of Nvidia earnings drove U.S. futures and benchmarks lower. The ETF saw $170 million in net inflows over five sessions, with Nvidia, Apple, and Microsoft as top holdings. SCHB completed a 3-for-1 split on Oct. 10, 2024. Both VTI and SCHB charge 0.03% but track different indexes and differ in holdings and assets.
18 November 2025
····
Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

U.S. stocks fell for a fourth straight session Tuesday, with the Dow down nearly 500 points intraday and the Nasdaq off up to 1.5% as investors sold AI-linked shares and weighed fading odds of a December Fed rate cut. Tesla, Palantir, and Super Micro Computer posted notable declines. Nvidia’s earnings report Wednesday looms, with options markets bracing for a 7% swing. A Cloudflare outage briefly disrupted major tech services, adding to sector jitters.
18 November 2025
········
Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Rothschild & Co Redburn downgraded Microsoft and Amazon to Neutral from Buy on Tuesday, citing concerns over capital intensity and slower AI monetization. Analyst Alex Haissl cut Microsoft’s price target to $500 and left Amazon’s at $250. Both stocks fell over 3% intraday, underperforming the market. The move contrasts with widespread bullish sentiment among Wall Street peers.
18 November 2025
····
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Today, November 18, 2025: AI Supercomputer Win, Citi “King of the Hill” Call Clash With 5% Selloff

AMD shares fell 5.6% to $226.95 at Tuesday’s close, despite a new European supercomputer contract and upbeat analyst commentary. The drop made AMD one of the biggest drags on the Nasdaq-100, as tech stocks broadly declined on macroeconomic worries and valuation concerns. Trading volume reached 18.5 million shares, below last week’s levels. AMD remains up about 100% over the past year.
18 November 2025
···
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk Stock Today (Nov 18, 2025): $199 Wegovy/Ozempic Intro Offer Drives Focus; Controlling Shareholder Sells ConvaTec Stake; NVO Edges Lower

Novo Nordisk cut U.S. self-pay prices for Wegovy and Ozempic and launched a $199 two-month introductory offer for new patients. Shares fell 1.9% to $47.55 intraday as investors weighed pricing pressure and governance changes. Novo Holdings exited its 7.8% stake in ConvaTec in London. Trading volumes reached about 7.9 million shares by 16:12 UTC.
18 November 2025
··
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Stock Today, Nov 18, 2025: Shares Jump on Winrevair Phase 2 Win as Cidara Deal Builds Flu Portfolio

Merck shares rose about 3%–4% Tuesday after the company said its drug Winrevair met the main goal in a Phase 2 study for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction. Merck plans to advance the drug to Phase 3 trials. The update follows last week’s $9.2 billion deal to acquire Cidara Therapeutics.
18 November 2025
··
Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer Stock Today (Nov. 18, 2025): PFE steadies near $25 as Pfizer launches multi‑tranche bond sale to help fund Metsera deal

Pfizer launched a U.S. dollar bond sale aiming to raise at least $5 billion to help fund its recent Metsera acquisition, which closed Nov. 13 for up to $10 billion. The offering may include up to seven tranches, with early talks on a 40-year note at about 125 basis points over Treasuries. Pfizer shares traded near $25.11 as of 16:12 UTC, little changed on the day.
18 November 2025
·····
Micron (MU) Stock Skyrockets to Record High on AI Frenzy – Analysts See More Upside

Micron Stock Today (Nov 18, 2025): MU Slides ~5.8% as Risk-Off Mood Hits Tech; HBM4 Supply Chatter, Zacks Highlight and Vanguard Stake in Focus

Micron Technology shares fell 5.8% to $228.00 by 16:11 UTC Tuesday, tracking a broader tech selloff ahead of Nvidia’s earnings and amid new supply-chain headlines. The stock opened at $235.24 and ranged between $225.70 and $241.75 intraday. A DigiTimes Asia report on Samsung’s HBM4 outlook and sector volatility pressured memory chipmakers. Micron closed Monday at $241.95.
18 November 2025
·
Alphabet (GOOGL, GOOG) Stock Today – November 18, 2025: AI Bubble Warnings, Buffett’s Big Bet and a Fresh Wall Street Upgrade

Alphabet (GOOGL, GOOG) Stock Today – November 18, 2025: AI Bubble Warnings, Buffett’s Big Bet and a Fresh Wall Street Upgrade

Alphabet shares fell about 2% midday Tuesday to $279–$280 amid a broader tech selloff. CEO Sundar Pichai warned in a BBC interview that no company, including Alphabet, is immune if an AI bubble bursts. Berkshire Hathaway’s recent multi-billion-dollar stake and a Loop Capital upgrade to Buy with a higher target continued to drive market interest. Alphabet’s market cap neared $3 trillion after hitting record highs last week.
18 November 2025
··
Cloudflare (NET) Stock Soars to Record High on Earnings and AI Buzz – What’s Next for Investors?

Cloudflare Stock (NET) Falls After Global Outage Hits X and ChatGPT – Price and News for November 18, 2025

Cloudflare shares closed at $195.84 on Tuesday, down about 3% after a major outage disrupted X, ChatGPT, Spotify, and crypto platforms before services recovered. The stock has dropped roughly 15% in a week but remains up over 80% in 2025, with a market value near $71 billion. Trading volume topped 5.1 million shares, well above average.
18 November 2025
····
Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

U.S. stocks fell Tuesday, with the Dow down nearly 1%, the S&P 500 off 0.5%, and the Nasdaq 100 slipping 0.9% by late morning. Renewed fears of an AI bubble ahead of Nvidia’s earnings and a weaker outlook from Home Depot fueled the decline. All three indexes hovered near one-month lows, extending Monday’s losses. Home Depot shares dropped over 3% after missing profit estimates.
18 November 2025
·····
Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals shares surged as much as 220% in pre-market trading on November 18 after Roche announced a Phase 3 win for its oral SERD giredestrant in early-stage breast cancer. The spike was driven by investor read-through to Olema’s similar drug palazestrant, not new Olema data. Volume hit 13.4 million shares, far above average. Shares later retreated toward the low-$20s during regular trading.
18 November 2025
·····
1 … 1,379 1,380 1,381 1,382 1,383 … 1,550

Stock Market Today

  • Korn Ferry (KFY) Stock Valuation: Momentum Builds Amid Modest Undervaluation
    June 13, 2026, 11:45 AM EDT. Korn Ferry's (KFY) stock rose about 14% in the last month and 21% over three months, driven by steady fundamentals including annual revenue of $2.86 billion and a market capitalization near $3.8 billion. Trading at $73.22, the share price sits roughly 8% below analysts' average target and nearly 47% below intrinsic value estimates, suggesting a potential buying opportunity. The consensus fair value of $75.50 points to a modest 3% undervaluation. Growth prospects hinge on Korn Ferry's expansion into larger markets and maintaining strong consulting demand. However, risks include pricing pressures and slower contract conversions. Investors are advised to review the company's financials and market position closely before decision-making.

Latest articles

Annaly Capital Stock Holds Near $22 After Dividend Hike as Investors Eye Fed Rate Catalyst

Annaly Capital Stock Holds Near $22 After Dividend Hike as Investors Eye Fed Rate Catalyst

13 June 2026
Annaly Capital Management hiked its quarterly dividend to $0.75 per share, boosting its annualized yield to about 13.6% at Friday’s $22.00 close; shares finished nearly flat as investors weighed the higher payout against ongoing interest rate and mortgage market risks, with analyst consensus showing a “Moderate Buy” and an average 12-month price target of $24.22.
Go toTop